HemeScreen® AML

Precipio’s HemeScreen™ AML Panel offerings screen for clinically actionable somatic mutations in targets of interest related to AML. This Research Use Only (RUO) reagent set is specifically designed to screen for mutations using High Resolution Melt Analysis in genes that are of clinical relevance: IDH1, IDH2, FLT3, KIT, CEBPA, and NPM1. The HemeScreen™ panel pre-plated plate contains the components, including Wild-Type controls, to perform PCR amplification followed by High Resolution Melt Analysis.